Adult-onset Still Disease
📧 Sign up to get email alerts when something new happens for Adult-onset Still Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-11-15Clinical Trial Update: Efficacy and Safety Clinical Study of RPH-104 in Adult Onset Still's Disease (AOSD) [Phase 3]
A Phase 3 trial of the investigative agent RPH-104 for Adult-Onset Still's Disease has been withdrawn, and will not proceed as planned.